Modulation of cyclophosphamide-induced early lung injury by allicin

Pharmaceutical Biology

Volumn 51, Issue 6, 2013, Pages 806-811

  Ashry, Nora A ^a   Gameil, Nariman M ^a   Suddek, Ghada M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Allicin; Antiinflammatory; Antioxidant; Cyclophosphamide; Lung; Rats; Tumor necrosis factor

Indexed keywords

ALLICIN; ALLIMAX; CYCLOPHOSPHAMIDE; GLUTATHIONE; LACTATE DEHYDROGENASE; LIPID HYDROPEROXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; LIPID PEROXIDATION; LUNG HOMOGENATE; LUNG INJURY; LUNG TOXICITY; MALE; NONHUMAN; ONSET AGE; PROTEIN EXPRESSION; RAT; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIOXIDANTS; BIOLOGICAL MARKERS; CYCLOPHOSPHAMIDE; FREE RADICAL SCAVENGERS; INJECTIONS, INTRAPERITONEAL; LIPID PEROXIDATION; LUNG INJURY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SULFINIC ACIDS; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877813945     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.766895     Document Type: Article

References (40)

1. Banerjee SK, Maulik M, Mancahanda SC, et al. (2002). Dose dependent induction of endogenous antioxidants in rat heart by chronic administration of garlic. Life Sci 70:1509-18. (Pubitemid 34164545)
2. Bruck R, Aeed H, Brazovsky E, et al. (2005). Allicin, the active component of garlic, prevents immune-mediated, concanavalin A-induced hepatic injury in mice. Liver Int 25:613-21. (Pubitemid 40861911)
3. Bukowski RM. (1996). The need for cytoprotection. Eur J Cancer 32A:S2-4.
4. Daba MH, Abdel-Aziz AH, Moustafa AM, et al. (2002). Effects of L-carnitine and Ginkgo biloba extract (EGb 761) in experimental bleomycin-induced lung fibrosis. Pharmacol Res 45:461-7. (Pubitemid 35304494)
5. Daniel WW. (1991). Biostatistics: A Foundation for Analysis in the Health Sciences. 5th ed. New York, Chichester, Brisbane, Toronto and Singapore: John Wiley & Sons.
6. Das UB, Mallick M, Debnath JM, Ghosh D. (2002). Protective effect of ascorbic acid on cyclophosphamide-induced testicular gametogenic and androgenic disorder in male rats. Asian J Androl 4:201-7.
7. Donato ML, Aleman A, Champlin RE, et al. (2004). Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 33:1219-24. (Pubitemid 38961480)
8. Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-7.
9. Fraiser LH, Kanekal S, Kehrer JP. (1991). Cyclophosphamide toxicity; characterizing and avoiding the problem. Drug 42:781-95. (Pubitemid 21920784)
10. Ghosh D, Das UB, Ghosh S, et al. (2002). Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: A correlative study with testicular oxidative stress. Drug Chem Toxicol 25:281-92. (Pubitemid 34831279)
11. Hales BF. (1982). Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard and acrolein. Cancer Res 42:3016-21. (Pubitemid 12041046)
12. Hasan N, Yusuf N, Toossi Z, Islam N. (2006). Suppression of Mycobacterium tuberculosis induced reactive oxygen species (ROS) and TNF-alpha mRNA expression in human monocytes by allicin. FEBS Lett 580:2517-22.
13. Hirano A, Shimizu T, Watanabe O, et al. (2008). Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer. Anticancer Res 28:4137-42.
14. Hodge G, Hodge S, Han P. (2002). Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: Potential therapeutic use in the treatment of inflammatory bowel disease. Cytometry 48:209-15. (Pubitemid 35333951)
15. Kim KM, Chun SB, Koo MS, et al. (2001). Differential regulation of NO availability from macrophages and endothelial cells by the garlic components S-allyl cystiene. Free Radic Biol Med 30:747-56.
16. Kumar S, Dhankhar N, Kar V, et al. (2011). Myocardial injury provoked by cyclophosphamide, protective aspect of hesperidin in rats. Int J Res Pharm Biomed Sci 2:1288-96.
17. Levine MN, Pritchard KI, Bramwell VH, et al. (2005). Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: Update of national cancer institute of Canada clinical trials group trial MA5. J Clin Oncol 23:5166-70. (Pubitemid 46224025)
18. Li XH, Li CY, Xiang ZG, et al. (2010). Allicin can reduce neuronal death and ameliorate the spatial memory impairment in Alzheimer's disease models. Neurosciences (Riyadh) 15:237-43.
19. Malik SW, Myers JL, DeRemee RA, Specks U. (1996). Lung toxicity associated with cyclophosphamide use: Two distinct patterns. Am J Respir Crit Care Med 154:1851-6. (Pubitemid 26424960)
20. Manda K, Bhatia AL. (2003). Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biol Toxicol 19:367-72. (Pubitemid 38250043)
21. Marklund SL. (1985). Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat Res 148:129-34. (Pubitemid 15151671)
22. McDiarmid MA, Iype PT, Kolodner K, et al. (1991). Evidence for acrolein-modified DNA in peripheral blood leucocytes of cancer patients treated with cyclophosphamide. Mutat Res 248:93-9.
23. Nagi MN, Mansour MA. (2000). Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: A possible mechanism of protection. Pharmacol Res 41:283-9. (Pubitemid 30663132)
24. Nicolini A, Mancini P, Ferrari P, et al. (2004). Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC). Biomed Pharmacother 58:447-50. (Pubitemid 39349493)
25. Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-8. (Pubitemid 9194347)
26. Patel JM. (1987). Stimulation of cyclophosphamide-induced pulmonary microsomal lipid peroxidation by oxygen. Toxicology 45:79-91. (Pubitemid 17104563)
27. Patel JM. (1990). Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol Ther 47:137-46. (Pubitemid 20183312)
28. Patel JM, Block ER. (1985). Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp Lung Res 8:153-65. (Pubitemid 15225703)
29. Prasad K, Laxdal VA, Yu M, Raney BL. (1995). Antioxidant activity of allicin, an active principle in garlic. Mol Cell Biochem 148:183-9.
30. Rao R, Shammo JM, Enschede SH, et al. (2005). The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colonystimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma. Clin Lymphoma 6:26-30.
31. Saravanan G, Prakash J. (2004). Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. J Ethnopharmacol 94:155-8. (Pubitemid 38949817)
32. Stankiewicz A, Skrzydlewska E, Makie?a M. (2002). Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabol. Drug Interact 19:67-82. (Pubitemid 36537996)
33. Sulkowska M, Sulkowski S. (1998). Alveolar cells in cyclophosphamideinduced lung injury: An ultrastructural analysis of type II alveolar epithelial cells in situ. Histol Histopathol 13:13-20. (Pubitemid 28044592)
34. Sulkowska M, Skrzydlewska E, Sobaniec-?otowska M, et al. (2002). Effect of cyclophosphamide-induced generation reactive oxygen forms on ultrastructure of the liver and lung. Bull Vet Inst Pulawy 46:239-46. (Pubitemid 36343819)
35. Sundstrom S, Bremnes RM, Kaasa S, et al. (2005). Second-line chemotherapy in recurrent small cell lung cancer: Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristine (CEV-regimen). Lung Cancer 48:251-61.
36. Tannehill SP, Mehta MP. (1996). Amifostine and radiation: Past, present and future. Semin Oncol 23:69-77. (Pubitemid 26321676)
37. Venkatesan N, Chandrakasan G. (1995). Modulation of cyclophosphamide- induced early lung injury by curcumin, an antiinflammatory antioxidant. Mol Cell Biochem 142:79-87.
38. Weijl NI, Cleton FJ, Osanto S. (1997). Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209-40. (Pubitemid 27464149)
39. Wu CC, Sheen LY, Chen HW, et al. (2001). Effects of organosulfur compounds from garlic oil on the antioxidation system in rat liver and red blood cells. Food Chem Toxicol 39:563-9. (Pubitemid 32429469)
40. Zhang J, Tian Q, Zhou S. (2006). Clinical pharmacology of cyclophosphamide and ifosfamide. Curr Drug Ther 1:55-84.